Urick, Mary Ellen
Bell, Daphne W. http://orcid.org/0000-0001-7314-3932
Article History
Accepted: 4 July 2019
First Online: 6 August 2019
Competing interests
: D.W.B. receives royalty income from US patent no. 7,294,468 ‘Method to determine responsiveness of cancer to epidermal growth factor receptor targeting treatments’, which is licensed to Esoterix Genetic Labs LLC. M.E.U. has no competing interests.